November 3, 2025

STAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit

October 30, 2025

WATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival

October 13, 2025

Now Enrolling: STOPGAP II trial opens for patients with stomach cancer

September 19, 2025

Now Enrolling: EAA241 trial opens for patients with newly diagnosed multiple myeloma and kidney failure

September 9, 2025

Dr. Suzanne Cole on using real-world data to improve the generalizability of clinical trial results (highlights PrE1702 and EA5182)

September 8, 2025

EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer

August 14, 2025

A new biomarker, KIM-1, may predict outcomes and response in kidney cancer (mentions E2805/ASSURE)

August 6, 2025

Treatment headway gives much-needed hope in small-cell lung cancer (discusses EA5161 and other trials)

August 5, 2025

Trial Spotlight: Dr. Ken Cardona gives an update on the STRASS 2 sarcoma trial (EA7211)

ECOG-ACRIN Cancer Research Group